Nutra Pharma Corp (NPHC) Receivables - Net (2011 - 2026)

Nutra Pharma has disclosed Receivables - Net across 16 years of filings, most recently posting $26454.0 for Q2 2026.

• In Q2 2026, Receivables - Net fell 24.9% year-over-year to $26454.0; the TTM figure through Jun 2026 stood at $26454.0 (down 24.9% YoY), while the FY2025 annual figure was $26060.0, up 9.7% from the prior year.
• Receivables - Net came in at $26454.0 for Q2 2026 at Nutra Pharma, roughly flat from $26345.0 in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $47313.0 in Q2 2022 to a low of $21580.0 in Q3 2022.
• Average Receivables - Net over 5 years is $26716.5, with a median of $23452.0 recorded in 2024.
• Year-over-year, Receivables - Net plunged 54.02% in 2023 and surged 55.91% in 2025.
• Over 5 years, Receivables - Net stood at $21664.0 in 2022, then advanced by 3.55% to $22433.0 in 2023, then grew by 5.89% to $23755.0 in 2024, then rose by 9.7% to $26060.0 in 2025, then gained by 1.51% to $26454.0 in 2026.
• Per Business Quant data, the three most recent Receivables - Net figures were $26454.0 in Q2 2026, $26345.0 in Q1 2026, and $26060.0 in Q4 2025.